| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/03/2006 | WO2005097064A3 Taste-masked drugs in rupturing multiparticulates |
| 08/03/2006 | WO2005089718A3 Pharmaceutical compositions |
| 08/03/2006 | WO2005087195A3 Novel compositions for topical delivery |
| 08/03/2006 | WO2005072710A3 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 08/03/2006 | WO2005070444A8 Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
| 08/03/2006 | WO2005065652A9 Non-aqueous composition for oral delivery of insoluble bioactive agents |
| 08/03/2006 | WO2005058474A9 Cryogranulation and storage method for active pharmaceutical agents |
| 08/03/2006 | WO2005039551A3 Solid pharmaceutical dosage form comprising an hiv protease inhibitor solid dispersion |
| 08/03/2006 | WO2004086412A3 Radiation protection by gamma-tocotrienol |
| 08/03/2006 | US20060173522 Anchoring of a medical device component adjacent a dura of the brain or spinal cord |
| 08/03/2006 | US20060173444 Ambulatory medical apparatus with hand held communication device |
| 08/03/2006 | US20060173443 Delivery system for therapy comprising hollow seed, preferably polymeric |
| 08/03/2006 | US20060173442 Delivery system for therapy comprising hollow seed, the method of use thereof |
| 08/03/2006 | US20060173339 Method, compounds and preparations for the identification of sentinel lymph nodes |
| 08/03/2006 | US20060173123 Ethylene polymer containing a liquid modifier composed of C20 to C1500 paraffins, especially oligomers of C5 to C14 olefins; improved flexibility, softness, clarity, tear resistance, low temperature impact resistance, and processibility, without loss in melting point |
| 08/03/2006 | US20060173079 Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 08/03/2006 | US20060173076 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060173060 Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems |
| 08/03/2006 | US20060173059 Agent for preventing or treating portal hypertension |
| 08/03/2006 | US20060172987 Amoxicillin trihydrate |
| 08/03/2006 | US20060172985 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension |
| 08/03/2006 | US20060172977 Topical administering an acetylcholine esterases inhibitor |
| 08/03/2006 | US20060172972 Formulation and method for administration of ophthalmologically active agents |
| 08/03/2006 | US20060172969 Citric acid, polyethylene glycol, and ofloxacin; low gelation temperatures; bioavailability |
| 08/03/2006 | US20060172955 Antibiotic/benzoyl peroxide dispenser |
| 08/03/2006 | US20060172949 administering a protein agonist for protease-activated receptor (PAR-2); side effects reduction; peptidase inhibitors (amistatins); drug delivery; biodrugs as antisecretory agents |
| 08/03/2006 | US20060172288 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role |
| 08/03/2006 | US20060172059 Method of inhibiting water content variation of composition and use thereof |
| 08/03/2006 | US20060172018 Nitric Oxide Delivery System |
| 08/03/2006 | US20060172011 Medical treatment |
| 08/03/2006 | US20060172010 Process for preparing particles containing an antiviral |
| 08/03/2006 | US20060172009 The formulation and presentation of medicaments |
| 08/03/2006 | US20060172008 formed from plasma proteins comprising fibrinogen, thrombin and Factor XIII, the matrix having less than 10% residual moisture and being devoid of external anti-fibrinolytic agents; sponges; useful as cell-bearing implants |
| 08/03/2006 | US20060172007 Compositions and methods for reducing vaginal pH |
| 08/03/2006 | US20060172006 Sustained-release tramadol formulations with 24-hour clinical efficacy |
| 08/03/2006 | US20060172005 Tablet and process for producing the same |
| 08/03/2006 | US20060172004 Oral compositions for the stimulation of gastric acid secretion comprising pentagastrin |
| 08/03/2006 | US20060172003 Modular targeted liposomal delivery system |
| 08/03/2006 | US20060172002 Patch containing nonsteroidal antinflammatory and analgesic agent |
| 08/03/2006 | US20060172001 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 08/03/2006 | US20060171999 Textiles with chitosan core-shell particles |
| 08/03/2006 | US20060171998 Sanitary Wipes and Seat Covers for gym equipment |
| 08/03/2006 | US20060171997 Self-inflating article |
| 08/03/2006 | US20060171996 Antibacterial pectocellulose |
| 08/03/2006 | US20060171994 Medicinal table with prolonged release of the active principle |
| 08/03/2006 | US20060171987 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix |
| 08/03/2006 | US20060171970 comprises diuretics and beta blockers; comprises buffer and osmotic adjusting agent; blister packs; for oral administration |
| 08/03/2006 | US20060171969 Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| 08/03/2006 | US20060171960 Methods and composition for oral vaccination |
| 08/03/2006 | US20060171916 water insoluble polyallylamine copolymer (hydrochloride) crosslinked with epichlorohydrin crosslinking agent; decreasing serum level of phosphate by binding phosphate in gastrointestinal tract, without increasing absorption of any clinically undesirable material, as calcium or aluminum; hyperphosphatemia |
| 08/03/2006 | US20060171899 Water-stabilized aerosol formulation system and method of making |
| 08/03/2006 | US20060171898 Corticosteroid-containing pharmaceutical composition |
| 08/03/2006 | US20060171897 Methods and formulations for the efficient delivery of drugs by nebulizer |
| 08/03/2006 | US20060171896 Buccal, polar and non-polar spray containing alprazolam |
| 08/03/2006 | US20060171895 Medical imaging reference devices |
| 08/03/2006 | US20060171888 Miniaturized device; substrate with reservoirs, openings; barriers layer covering aperture |
| 08/03/2006 | US20060169975 biosensors has the coated nanotubes or nanowires as nanoelectrodes; phospholipid layer has a protein pore that is sensitive to biowarfare agents; detecting bacteria, viruses and toxins; medical equipment |
| 08/03/2006 | US20060169287 Condom with male genital desensitizer lubricant |
| 08/03/2006 | DE60115402T2 Neues selbstemulgierendes arzneistoffverabreichungssystem New self-emulsifying drug delivery system |
| 08/03/2006 | DE202005019051U1 Topical agent, useful for constricting vagina during sexual interaction, comprises alum as an auxiliary agent |
| 08/03/2006 | CA2596548A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | CA2596240A1 Fast-disintegrating microporous binder and process for making it |
| 08/03/2006 | CA2596230A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | CA2596215A1 Nebulizer formulation of levalbuterol and ipratropium |
| 08/03/2006 | CA2596147A1 Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics |
| 08/03/2006 | CA2596131A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | CA2596058A1 Method of producing coated fine particles |
| 08/03/2006 | CA2596035A1 Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents |
| 08/03/2006 | CA2596029A1 Oral osmotic dosage form having a high flux membrane |
| 08/03/2006 | CA2595988A1 Extended release formulation of levetiracetam |
| 08/03/2006 | CA2595894A1 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment |
| 08/03/2006 | CA2595885A1 Controlled release compositions comprising an antipsychotic agent |
| 08/03/2006 | CA2595879A1 Analgesic compositions |
| 08/03/2006 | CA2595731A1 Lipid carrier compositions with reduced polydispersity |
| 08/03/2006 | CA2595651A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 08/03/2006 | CA2595615A1 Feminine anti-itch gel |
| 08/03/2006 | CA2595457A1 Control of drug release by transient modification of local microenvironments |
| 08/03/2006 | CA2595348A1 Stabilised plant extract and its therapeutic use |
| 08/03/2006 | CA2594991A1 Medical devices containing crazed polymeric release regions for drug delivery |
| 08/03/2006 | CA2594758A1 Delivery of bio-available compounds with anhydrous topical preparations |
| 08/03/2006 | CA2594694A1 Drying of drug-containing particles |
| 08/03/2006 | CA2594667A1 Compositions and therapeutic methods utilizing a combination of a 5-ht1f inhibitor and an nsaid |
| 08/03/2006 | CA2594373A1 Alcohol resistant dosage forms |
| 08/03/2006 | CA2593825A1 Solid dispersion comprising tacrolimus and enteric-coated macromolecule |
| 08/03/2006 | CA2593801A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/03/2006 | CA2590338A1 Compositions and methods for treating cardiac conditions |
| 08/03/2006 | CA2587677A1 High concentration self-microemulsifying coenzyme q10 preparations for nutritional use |
| 08/03/2006 | CA2571899A1 Targeted and high density drug loaded polymeric materials |
| 08/02/2006 | EP1686163A2 Solution of pressure sensitive adhesives based on acrylic block copolymers |
| 08/02/2006 | EP1686162A2 Tape Preparation |
| 08/02/2006 | EP1685942A1 Pressure sensitive adhesives containing an active substance and their manufacturing process |
| 08/02/2006 | EP1685876A1 Solid cosmetic cleansing composition |
| 08/02/2006 | EP1685846A1 Antitumor agent |
| 08/02/2006 | EP1685839A1 Pharmaceutical oral dosage form comprising a combination of an opioid agonist and opioid antagonist |
| 08/02/2006 | EP1685837A1 Percutaneous absorption type cerebral protective agent |
| 08/02/2006 | EP1685831A1 Pharmaceutical polymer composition for oral controlled release delivery of terbutaline sulfate |
| 08/02/2006 | EP1685830A1 Plaster |
| 08/02/2006 | EP1685828A1 Solid pharmaceutical composition comprising tilidine hydrochloride |
| 08/02/2006 | EP1685797A1 Device and method for examining a body lumen |
| 08/02/2006 | EP1685376A2 Viral fibers |